Related Experiment Video
Updated: Jun 4, 2026
08:33
Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
Published on: July 18, 2025
[Technical innovations and limitation in cardiac electrotherapy]
1Klinik für Innere Medizin/Kardiologie, Oberhavel-Kliniken, Marwitzer Str. 91, 16761, Hennigsdorf, Deutschland. minden@oberhavel-kliniken.de
Herzschrittmachertherapie & Elektrophysiologie
|February 24, 2011
Summary
Achieving optimal coronary sinus lead placement is crucial for cardiac resynchronization therapy (CRT) success. New catheter and lead technologies aim to overcome implantation challenges and improve lead performance, avoiding phrenic nerve stimulation (PNS).
Area of Science:
- Cardiovascular Medicine
- Medical Device Technology
Context:
- Coronary sinus (CS) lead positioning is critical for effective cardiac resynchronization therapy (CRT).
- Technical difficulties during CS lead implantation can compromise stability and performance.
- Phrenic nerve stimulation (PNS) is a common complication that can arise.
Purpose:
- To present novel advancements in catheter and lead technology.
- To address the challenges associated with stable and effective CS lead implantation.
- To improve CRT outcomes by mitigating implantation-related complications like PNS.
Summary:
- This work reviews new developments in catheter and lead technologies designed for coronary sinus lead implantation.
- These innovations aim to surmount technical hurdles encountered during the procedure.
- The goal is to ensure stable lead positioning and optimal performance without inducing phrenic nerve stimulation.
Impact:
- Potential to enhance the success rates of cardiac resynchronization therapy.
- May lead to improved patient outcomes by ensuring reliable CRT device function.
- Offers solutions for clinicians facing challenges in complex CS lead placements.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:28Electrocardiogram Fundamentals
Introduction
An electrocardiogram (ECG) is a diagnostic tool for identifying cardiac conditions such as arrhythmias, conduction abnormalities, and myocardial ischemia.
Definition
An electrocardiogram (ECG) visualizes the heart's electrical activity by tracing the electrical movement associated with each heartbeat on a graph or monitor. As the heart beats, an electrical wave passes through it, correlating with the cardiac cycle events.
Parts of an ECG
An ECG utilizes electrodes on the skin to...
An electrocardiogram (ECG) is a diagnostic tool for identifying cardiac conditions such as arrhythmias, conduction abnormalities, and myocardial ischemia.
Definition
An electrocardiogram (ECG) visualizes the heart's electrical activity by tracing the electrical movement associated with each heartbeat on a graph or monitor. As the heart beats, an electrical wave passes through it, correlating with the cardiac cycle events.
Parts of an ECG
An ECG utilizes electrodes on the skin to...
01:30Cardiac Action Potential
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...